Teva Pharmaceuticals CEO Richard Francis reflects on company performance in 2024, drug pricing, getting more drugs to market and supply shortages of the drug Adderall.
He speaks to Bloomberg's Katie Griefeld from the JPMorgan Healthcare Conference.

Former US National Security Advisor Jake Sullivan Talks US-Iran Peace
16:05

Bank of Israel Governor Amir Yaron Talks Israel's Economy
08:35

The RealReal CEO Rati Levesque Talks Luxury Resale Boom
07:42